Industry Research Reports
Home > Reports > Pharma & Healthcare > Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
NAD+ Intravenous Therapy Market Size(US$)
CAGR 2024-2030
7.5%
Market Size,2030
USD 449
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 291 million
Market Forecast in 2030(Value)
US$ 449 million
CAGR
7.5%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 449 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
NAD+ IV Therapy is a wellness therapy that involves the intravenous administration of nicotinamide adenine dinucleotide (NAD+), a coenzyme crucial for cellular energy production and metabolic processes. This therapy is believed to boost energy levels, enhance cognitive function, and promote overall cellular repair by increasing NAD+ levels, which naturally decline with age.
The US & Canada market for NAD+ Intravenous Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for NAD+ Intravenous Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for NAD+ Intravenous Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of NAD+ Intravenous Therapy include The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for NAD+ Intravenous Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of NAD+ Intravenous Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for NAD+ Intravenous Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the NAD+ Intravenous Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global NAD+ Intravenous Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for NAD+ Intravenous Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, etc.
Market Segmentation
By Company
- The Wellness Lab
- Conciergemdla
- Azivmedics
- Reset IV
- Thedripclub
- Toronto Functional Medicine Centre
- Mobileivmedics
- Rocky Mountain Ivmedics
- Seaside Skin Care
- Premiumhealth
- Effect Doctors
- Nadclinic
- Hydrate IV Bar
- LIVV Natural
- BioReset Medical
- IV Boost UK
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Segment by Application
- Clinic
- Hospital
- Residential
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of NAD+ Intravenous Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NAD+ Intravenous Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NAD+ Intravenous Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NAD+ Intravenous Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NAD+ Mixed Vitamin Injections
1.2.3 Pure NAD+ Injection
1.3 Market by Application
1.3.1 Global NAD+ Intravenous Therapy Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Residential
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NAD+ Intravenous Therapy Market Perspective (2019-2030)
2.2 Global NAD+ Intravenous Therapy Growth Trends by Region
2.2.1 Global NAD+ Intravenous Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NAD+ Intravenous Therapy Historic Market Size by Region (2019-2024)
2.2.3 NAD+ Intravenous Therapy Forecasted Market Size by Region (2025-2030)
2.3 NAD+ Intravenous Therapy Market Dynamics
2.3.1 NAD+ Intravenous Therapy Industry Trends
2.3.2 NAD+ Intravenous Therapy Market Drivers
2.3.3 NAD+ Intravenous Therapy Market Challenges
2.3.4 NAD+ Intravenous Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue NAD+ Intravenous Therapy by Players
3.1.1 Global NAD+ Intravenous Therapy Revenue by Players (2019-2024)
3.1.2 Global NAD+ Intravenous Therapy Revenue Market Share by Players (2019-2024)
3.2 Global NAD+ Intravenous Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of NAD+ Intravenous Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global NAD+ Intravenous Therapy Market Concentration Ratio
3.4.1 Global NAD+ Intravenous Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NAD+ Intravenous Therapy Revenue in 2023
3.5 Global Key Players of NAD+ Intravenous Therapy Head office and Area Served
3.6 Global Key Players of NAD+ Intravenous Therapy, Product and Application
3.7 Global Key Players of NAD+ Intravenous Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NAD+ Intravenous Therapy Breakdown Data by Type
4.1 Global NAD+ Intravenous Therapy Historic Market Size by Type (2019-2024)
4.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Type (2025-2030)
5 NAD+ Intravenous Therapy Breakdown Data by Application
5.1 Global NAD+ Intravenous Therapy Historic Market Size by Application (2019-2024)
5.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NAD+ Intravenous Therapy Market Size (2019-2030)
6.2 North America NAD+ Intravenous Therapy Market Size by Type
6.2.1 North America NAD+ Intravenous Therapy Market Size by Type (2019-2024)
6.2.2 North America NAD+ Intravenous Therapy Market Size by Type (2025-2030)
6.2.3 North America NAD+ Intravenous Therapy Market Share by Type (2019-2030)
6.3 North America NAD+ Intravenous Therapy Market Size by Application
6.3.1 North America NAD+ Intravenous Therapy Market Size by Application (2019-2024)
6.3.2 North America NAD+ Intravenous Therapy Market Size by Application (2025-2030)
6.3.3 North America NAD+ Intravenous Therapy Market Share by Application (2019-2030)
6.4 North America NAD+ Intravenous Therapy Market Size by Country
6.4.1 North America NAD+ Intravenous Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America NAD+ Intravenous Therapy Market Size by Country (2019-2024)
6.4.3 North America NAD+ Intravenous Therapy Market Share by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe NAD+ Intravenous Therapy Market Size (2019-2030)
7.2 Europe NAD+ Intravenous Therapy Market Size by Type
7.2.1 Europe NAD+ Intravenous Therapy Market Size by Type (2019-2024)
7.2.2 Europe NAD+ Intravenous Therapy Market Size by Type (2025-2030)
7.2.3 Europe NAD+ Intravenous Therapy Market Share by Type (2019-2030)
7.3 Europe NAD+ Intravenous Therapy Market Size by Application
7.3.1 Europe NAD+ Intravenous Therapy Market Size by Application (2019-2024)
7.3.2 Europe NAD+ Intravenous Therapy Market Size by Application (2025-2030)
7.3.3 Europe NAD+ Intravenous Therapy Market Share by Application (2019-2030)
7.4 Europe NAD+ Intravenous Therapy Market Size by Country
7.4.1 Europe NAD+ Intravenous Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe NAD+ Intravenous Therapy Market Size by Country (2019-2024)
7.4.3 Europe NAD+ Intravenous Therapy Market Size by Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.4.9 Nordic Countries
8 China
8.1 China NAD+ Intravenous Therapy Market Size (2019-2030)
8.2 China NAD+ Intravenous Therapy Market Size by Type
8.2.1 China NAD+ Intravenous Therapy Market Size by Type (2019-2024)
8.2.2 China NAD+ Intravenous Therapy Market Size by Type (2025-2030)
8.2.3 China NAD+ Intravenous Therapy Market Share by Type (2019-2030)
8.3 China NAD+ Intravenous Therapy Market Size by Application
8.3.1 China NAD+ Intravenous Therapy Market Size by Application (2019-2024)
8.3.2 China NAD+ Intravenous Therapy Market Size by Application (2025-2030)
8.3.3 China NAD+ Intravenous Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia NAD+ Intravenous Therapy Market Size (2019-2030)
9.2 Asia NAD+ Intravenous Therapy Market Size by Type
9.2.1 Asia NAD+ Intravenous Therapy Market Size by Type (2019-2024)
9.2.2 Asia NAD+ Intravenous Therapy Market Size by Type (2025-2030)
9.2.3 Asia NAD+ Intravenous Therapy Market Share by Type (2019-2030)
9.3 Asia NAD+ Intravenous Therapy Market Size by Application
9.3.1 Asia NAD+ Intravenous Therapy Market Size by Application (2019-2024)
9.3.2 Asia NAD+ Intravenous Therapy Market Size by Application (2025-2030)
9.3.3 Asia NAD+ Intravenous Therapy Market Share by Application (2019-2030)
9.4 Asia NAD+ Intravenous Therapy Market Size by Region
9.4.1 Asia NAD+ Intravenous Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia NAD+ Intravenous Therapy Market Size by Region (2019-2024)
9.4.3 Asia NAD+ Intravenous Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 The Wellness Lab
11.1.1 The Wellness Lab Company Details
11.1.2 The Wellness Lab Business Overview
11.1.3 The Wellness Lab NAD+ Intravenous Therapy Introduction
11.1.4 The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.1.5 The Wellness Lab Recent Development
11.2 Conciergemdla
11.2.1 Conciergemdla Company Details
11.2.2 Conciergemdla Business Overview
11.2.3 Conciergemdla NAD+ Intravenous Therapy Introduction
11.2.4 Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.2.5 Conciergemdla Recent Development
11.3 Azivmedics
11.3.1 Azivmedics Company Details
11.3.2 Azivmedics Business Overview
11.3.3 Azivmedics NAD+ Intravenous Therapy Introduction
11.3.4 Azivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.3.5 Azivmedics Recent Development
11.4 Reset IV
11.4.1 Reset IV Company Details
11.4.2 Reset IV Business Overview
11.4.3 Reset IV NAD+ Intravenous Therapy Introduction
11.4.4 Reset IV Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.4.5 Reset IV Recent Development
11.5 Thedripclub
11.5.1 Thedripclub Company Details
11.5.2 Thedripclub Business Overview
11.5.3 Thedripclub NAD+ Intravenous Therapy Introduction
11.5.4 Thedripclub Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.5.5 Thedripclub Recent Development
11.6 Toronto Functional Medicine Centre
11.6.1 Toronto Functional Medicine Centre Company Details
11.6.2 Toronto Functional Medicine Centre Business Overview
11.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Introduction
11.6.4 Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.6.5 Toronto Functional Medicine Centre Recent Development
11.7 Mobileivmedics
11.7.1 Mobileivmedics Company Details
11.7.2 Mobileivmedics Business Overview
11.7.3 Mobileivmedics NAD+ Intravenous Therapy Introduction
11.7.4 Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.7.5 Mobileivmedics Recent Development
11.8 Rocky Mountain Ivmedics
11.8.1 Rocky Mountain Ivmedics Company Details
11.8.2 Rocky Mountain Ivmedics Business Overview
11.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Introduction
11.8.4 Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.8.5 Rocky Mountain Ivmedics Recent Development
11.9 Seaside Skin Care
11.9.1 Seaside Skin Care Company Details
11.9.2 Seaside Skin Care Business Overview
11.9.3 Seaside Skin Care NAD+ Intravenous Therapy Introduction
11.9.4 Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.9.5 Seaside Skin Care Recent Development
11.10 Premiumhealth
11.10.1 Premiumhealth Company Details
11.10.2 Premiumhealth Business Overview
11.10.3 Premiumhealth NAD+ Intravenous Therapy Introduction
11.10.4 Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.10.5 Premiumhealth Recent Development
11.11 Effect Doctors
11.11.1 Effect Doctors Company Details
11.11.2 Effect Doctors Business Overview
11.11.3 Effect Doctors NAD+ Intravenous Therapy Introduction
11.11.4 Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.11.5 Effect Doctors Recent Development
11.12 Nadclinic
11.12.1 Nadclinic Company Details
11.12.2 Nadclinic Business Overview
11.12.3 Nadclinic NAD+ Intravenous Therapy Introduction
11.12.4 Nadclinic Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.12.5 Nadclinic Recent Development
11.13 Hydrate IV Bar
11.13.1 Hydrate IV Bar Company Details
11.13.2 Hydrate IV Bar Business Overview
11.13.3 Hydrate IV Bar NAD+ Intravenous Therapy Introduction
11.13.4 Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.13.5 Hydrate IV Bar Recent Development
11.14 LIVV Natural
11.14.1 LIVV Natural Company Details
11.14.2 LIVV Natural Business Overview
11.14.3 LIVV Natural NAD+ Intravenous Therapy Introduction
11.14.4 LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.14.5 LIVV Natural Recent Development
11.15 BioReset Medical
11.15.1 BioReset Medical Company Details
11.15.2 BioReset Medical Business Overview
11.15.3 BioReset Medical NAD+ Intravenous Therapy Introduction
11.15.4 BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.15.5 BioReset Medical Recent Development
11.16 IV Boost UK
11.16.1 IV Boost UK Company Details
11.16.2 IV Boost UK Business Overview
11.16.3 IV Boost UK NAD+ Intravenous Therapy Introduction
11.16.4 IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2019-2024)
11.16.5 IV Boost UK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global NAD+ Intravenous Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of NAD+ Mixed Vitamin Injections
Table 3. Key Players of Pure NAD+ Injection
Table 4. Global NAD+ Intravenous Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global NAD+ Intravenous Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global NAD+ Intravenous Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global NAD+ Intravenous Therapy Market Share by Region (2019-2024)
Table 8. Global NAD+ Intravenous Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global NAD+ Intravenous Therapy Market Share by Region (2025-2030)
Table 10. NAD+ Intravenous Therapy Market Trends
Table 11. NAD+ Intravenous Therapy Market Drivers
Table 12. NAD+ Intravenous Therapy Market Challenges
Table 13. NAD+ Intravenous Therapy Market Restraints
Table 14. Global NAD+ Intravenous Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global NAD+ Intravenous Therapy Market Share by Players (2019-2024)
Table 16. Global Top NAD+ Intravenous Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Intravenous Therapy as of 2023)
Table 17. Global NAD+ Intravenous Therapy Industry Ranking 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by NAD+ Intravenous Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of NAD+ Intravenous Therapy, Headquarters and Area Served
Table 20. Global Key Players of NAD+ Intravenous Therapy, Product and Application
Table 21. Global Key Players of NAD+ Intravenous Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global NAD+ Intravenous Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global NAD+ Intravenous Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America NAD+ Intravenous Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America NAD+ Intravenous Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America NAD+ Intravenous Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe NAD+ Intravenous Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe NAD+ Intravenous Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe NAD+ Intravenous Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. China NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 46. China NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 47. China NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 48. China NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia NAD+ Intravenous Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia NAD+ Intravenous Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia NAD+ Intravenous Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 63. The Wellness Lab Company Details
Table 64. The Wellness Lab Business Overview
Table 65. The Wellness Lab NAD+ Intravenous Therapy Product
Table 66. The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 67. The Wellness Lab Recent Development
Table 68. Conciergemdla Company Details
Table 69. Conciergemdla Business Overview
Table 70. Conciergemdla NAD+ Intravenous Therapy Product
Table 71. Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 72. Conciergemdla Recent Development
Table 73. Azivmedics Company Details
Table 74. Azivmedics Business Overview
Table 75. Azivmedics NAD+ Intravenous Therapy Product
Table 76. Azivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 77. Azivmedics Recent Development
Table 78. Reset IV Company Details
Table 79. Reset IV Business Overview
Table 80. Reset IV NAD+ Intravenous Therapy Product
Table 81. Reset IV Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 82. Reset IV Recent Development
Table 83. Thedripclub Company Details
Table 84. Thedripclub Business Overview
Table 85. Thedripclub NAD+ Intravenous Therapy Product
Table 86. Thedripclub Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 87. Thedripclub Recent Development
Table 88. Toronto Functional Medicine Centre Company Details
Table 89. Toronto Functional Medicine Centre Business Overview
Table 90. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product
Table 91. Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 92. Toronto Functional Medicine Centre Recent Development
Table 93. Mobileivmedics Company Details
Table 94. Mobileivmedics Business Overview
Table 95. Mobileivmedics NAD+ Intravenous Therapy Product
Table 96. Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 97. Mobileivmedics Recent Development
Table 98. Rocky Mountain Ivmedics Company Details
Table 99. Rocky Mountain Ivmedics Business Overview
Table 100. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product
Table 101. Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 102. Rocky Mountain Ivmedics Recent Development
Table 103. Seaside Skin Care Company Details
Table 104. Seaside Skin Care Business Overview
Table 105. Seaside Skin Care NAD+ Intravenous Therapy Product
Table 106. Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 107. Seaside Skin Care Recent Development
Table 108. Premiumhealth Company Details
Table 109. Premiumhealth Business Overview
Table 110. Premiumhealth NAD+ Intravenous Therapy Product
Table 111. Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 112. Premiumhealth Recent Development
Table 113. Effect Doctors Company Details
Table 114. Effect Doctors Business Overview
Table 115. Effect Doctors NAD+ Intravenous Therapy Product
Table 116. Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 117. Effect Doctors Recent Development
Table 118. Nadclinic Company Details
Table 119. Nadclinic Business Overview
Table 120. Nadclinic NAD+ Intravenous Therapy Product
Table 121. Nadclinic Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 122. Nadclinic Recent Development
Table 123. Hydrate IV Bar Company Details
Table 124. Hydrate IV Bar Business Overview
Table 125. Hydrate IV Bar NAD+ Intravenous Therapy Product
Table 126. Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 127. Hydrate IV Bar Recent Development
Table 128. LIVV Natural Company Details
Table 129. LIVV Natural Business Overview
Table 130. LIVV Natural NAD+ Intravenous Therapy Product
Table 131. LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 132. LIVV Natural Recent Development
Table 133. BioReset Medical Company Details
Table 134. BioReset Medical Business Overview
Table 135. BioReset Medical NAD+ Intravenous Therapy Product
Table 136. BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 137. BioReset Medical Recent Development
Table 138. IV Boost UK Company Details
Table 139. IV Boost UK Business Overview
Table 140. IV Boost UK NAD+ Intravenous Therapy Product
Table 141. IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 142. IV Boost UK Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NAD+ Intravenous Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global NAD+ Intravenous Therapy Market Share by Type: 2023 VS 2030
Figure 3. NAD+ Mixed Vitamin Injections Features
Figure 4. Pure NAD+ Injection Features
Figure 5. Global NAD+ Intravenous Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global NAD+ Intravenous Therapy Market Share by Application: 2023 VS 2030
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Residential Case Studies
Figure 10. NAD+ Intravenous Therapy Report Years Considered
Figure 11. Global NAD+ Intravenous Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global NAD+ Intravenous Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global NAD+ Intravenous Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global NAD+ Intravenous Therapy Market Share by Players in 2023
Figure 15. Global Top NAD+ Intravenous Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Intravenous Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by NAD+ Intravenous Therapy Revenue in 2023
Figure 17. North America NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 19. North America NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 20. North America NAD+ Intravenous Therapy Market Share by Country (2019-2030)
Figure 21. United States NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 25. Europe NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 26. Europe NAD+ Intravenous Therapy Market Share by Country (2019-2030)
Figure 27. Germany NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 35. China NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 36. Asia NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 38. Asia NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 39. Asia NAD+ Intravenous Therapy Market Share by Region (2019-2030)
Figure 40. Japan NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America NAD+ Intravenous Therapy Market Share by Country (2019-2030)
Figure 50. Brazil NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries NAD+ Intravenous Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. The Wellness Lab Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 57. Conciergemdla Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 58. Azivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 59. Reset IV Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 60. Thedripclub Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 61. Toronto Functional Medicine Centre Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 62. Mobileivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 63. Rocky Mountain Ivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 64. Seaside Skin Care Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 65. Premiumhealth Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 66. Effect Doctors Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 67. Nadclinic Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 68. Hydrate IV Bar Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 69. LIVV Natural Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 70. BioReset Medical Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 71. IV Boost UK Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Related Reports
Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
The global NAD+ Intravenous Therapy revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 449 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published Date: 2024-11-11
Pages: 131
USD 4350.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published Date: 2024-11-11
Pages: 100
USD 2900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 125
USD 3950.00
(Single User License)
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NAD+ Intravenous Therapy market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 105
USD 4250.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 117
USD 2900.00
(Single User License)
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 105
USD 3950.00
(Single User License)
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 133
USD 4900.00
(Single User License)
Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
The global NAD+ Intravenous Therapy revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 449 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published: 2024-11-11
Pages: 131
USD 4350.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published: 2024-11-11
Pages: 100
USD 2900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-03-13
Pages: 97
USD 2900.00 (Single User License)NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 125
USD 3950.00 (Single User License)Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NAD+ Intravenous Therapy market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 105
USD 4250.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 117
USD 2900.00 (Single User License)NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 105
USD 3950.00 (Single User License)Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
USD 4250.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 133
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research